newsfilter
← Latest News
FDA Approved Drugs·

Approval of Rhapsido, Nda #218436 (Efficacy)

Approval Date: 10/06/2026; Drug Name: Rhapsido, Nda #218436; Active Ingredients: REMIBRUTINIB; Company: Novartis; Submission Status: Approval; Submission Classification: Efficacy; Application Number: 218436

Company
NOVARTIS
Keywords
NOVARTIS